<?xml version="1.0" encoding="UTF-8"?><!-- EDGARfilingagent.com Schedule 13D/G Online Workstation (https://schedule13d.com) --><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
	<submissionType>SCHEDULE 13G/A</submissionType>
	<previousAccessionNumber>0001781002-21-000045</previousAccessionNumber>
	<filerInfo>
		<filer>
			<filerCredentials>
				<cik>0001781002</cik>
				<ccc>XXXXXXXX</ccc>
			</filerCredentials>
		</filer>
		<liveTestFlag>LIVE</liveTestFlag>



	</filerInfo>
</headerData>
<!-- Start Form -->
  <formData>
<!-- Issuer Cover Page-->
    <coverPageHeader>
		<amendmentNo>5</amendmentNo>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001872529</issuerCik>
        <issuerName>MDxHealth SA</issuerName>
        <issuerCusip>58286E102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>CAP Business Center</com:street1>
          <com:street2>Zone Industrielle des Hauts-Sarts</com:street2>
          <com:city>Herstal</com:city>
          <com:stateOrCountry>C9</com:stateOrCountry>
          <com:zipCode>4040</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
<!-- Reporting Persons Cover Page -->
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bleichroeder LP</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>7378333</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>7378333</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>7378333</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>14.9</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <comments>Relating to item 11 on this page: Based on 49,497,334 shares reported by the Issuer to be outstanding</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Bleichroeder Holdings LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>7378333</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>7378333</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>7378333</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>14.9</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
      <comments>Relating to item 11 on this page: Based on 49,497,334 shares reported by the Issuer to be outstanding</comments>
    </coverPageHeaderReportingPersonDetails>
<!-- Items -->
    <items>
      <item1>
        <issuerName>MDxHealth SA</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>CAP Business Center, Zone Industrielle des Hauts-Sarts, Herstal, C9  4040</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Bleichroeder Holdings LLC
Bleichroeder LP
</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>1345 Avenue of the Americas, 47th Floor
New York, NY 10105</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Delaware, USA</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
      <typeOfPersonFiling>IA</typeOfPersonFiling>
      <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See cover page</amountBeneficiallyOwned>
        <classPercent>See cover page</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See cover page</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See cover page</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See cover page</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See cover page</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>Bleichroeder LP ("Bleichroeder"), an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 7,378,333 shares, or 14.91%, of the common stock ("Common Stock") reported by the issuer as outstanding. 21 April Fund Ltd., a Cayman Islands company for which Bleichroeder acts as investment adviser, 4,014,216 of these 7,378,333 shares, which equates to 8.11% of Common Stock reported by the issuer as outstanding. Clients of Bleichroeder have the right to receive and the ultimate power to direct the receipt of dividends from, or the proceeds of the sale of, such securities.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>See exhibit 99.1</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
	<!-- Exhibit Information -->
	<exhibitInfo>Exhibit 99.1: Subsidiary Information</exhibitInfo>
	<!-- Signature -->
    <signatureInformation>
      <reportingPersonName>Bleichroeder LP</reportingPersonName>
      <signatureDetails>
        <signature>Michael M. Kellen</signature>
        <title>Chairman and Co-CEO</title>
        <date>02/13/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Bleichroeder Holdings LLC</reportingPersonName>
      <signatureDetails>
        <signature>Michael M. Kellen</signature>
        <title>Chairman and Co-CEO</title>
        <date>02/13/2025</date>
      </signatureDetails>
    </signatureInformation>
	</formData>

</edgarSubmission>